申请人:Medosan Industrie Biochimiche
Riunite S.p.A.
公开号:EP0122889A1
公开(公告)日:1984-10-24
1,4-Benzodiazepine compounds having the formula
wherein R is selected from the group comprising a lower alkyl with up to 5 carbon atoms, alkoxy with up to 4 carbon atoms, branched or straight chain; R, is selected from the group comprising H,-CH3,-CH2CH2N(C2H5)2; R2 and R3 are each individually selected from the group comprising H, Br, Cl, F, trifluoromethyl, N02; n is a whole enteger from 1 to 5 show useful and valuable pharmacological and therapeutic properties more specifically as anticonvulsivants, anti-epileptics, sedatives, hypnotics, muscle relaxants, analgesics, anxyoly- tics and tranquillizers.
1,4-苯并二氮杂卓化合物,其式如下
其中 R 选自由不超过 5 个碳原子的低级烷基、不超过 4 个碳原子的支链或直链 烷氧基组成的基团;R 选自由 H、-CH3、-CH2CH2N(C2H5)2 组成的基团;R2 和 R3 各自选自由 H、Br、Cl、F、三氟甲基、N02;n 为 1 至 5 的整数,具有有用和有价值的药理和治疗特性,特别是作为抗惊厥药、抗癫痫药、镇静剂、催眠药、肌肉松弛剂、镇痛药、抗氧剂和安定剂。